Highlight
– Defecation urgency in IBS is recognized as a multidimensional symptom influenced by sensory and emotional factors.
– Urgency measured by patient diaries and questionnaires strongly correlate but do not align with experimentally derived rectal sensation thresholds.
– Structural MRI identifies distinct gray matter volume differences in brain regions related to emotional processing and visceral sensation.
– Differentiating real-life urgency from experimentally induced sensations aids in understanding neural substrates underlying symptom perception in IBS.
Study Background
Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by abdominal pain and altered bowel habits. Among its distressing features, defecation urgency—a sudden and compelling need to pass stool—is prominent but poorly defined and understood. This symptom significantly impairs quality of life and is challenging to quantify clinically. The interplay between subjective symptom reporting and objective sensory testing, alongside the involvement of central neural mechanisms, remains inadequately characterized. Understanding the neural correlates of urgency may illuminate pathophysiological pathways and guide tailored management strategies.
Study Design
This cross-sectional study enrolled 150 patients with moderate to severe IBS attending a specialized gastroenterology clinic. Defecation urgency assessment used three approaches: real-life symptom diaries, self-reported questionnaires, and experimental evaluation of rectal sensation thresholds through barostat testing. The barostat measures rectal balloon distension pressures resulting in sensations of urgency.
Additionally, participants underwent high-resolution structural magnetic resonance imaging (MRI) to map regional gray matter volumes (GMV). Statistical analyses included nonparametric tests and partial correlations adjusted for confounders to explore associations between urgency metrics, clinical symptoms, and brain morphology.
Key Findings
Symptom Diary and Questionnaires:
Urgency measures from gastrointestinal diaries and questionnaires were highly correlated, confirming consistency between real-life and retrospective symptom reporting. These measures also correlated significantly with other abdominal symptoms, highlighting urgency’s integration into the symptom complex.
Barostat-Derived Urgency Thresholds:
Contrastingly, no significant associations were found between barostat-induced rectal urgency thresholds and symptom-based urgency measures. Experimental sensory thresholds demonstrated distinct relationships, notably correlating specifically with gastrointestinal-specific anxiety rather than broader abdominal symptoms.
Neuroimaging Results:
Structural MRI revealed divergent neural substrates related to symptom-based versus barostat-defined urgency. Lower symptom-based urgency correlated with decreased gray matter volume in bilateral pregenual anterior cingulate cortex (pACC), a region involved in affective and cognitive modulation of visceral pain and urgency. Moreover, increased GMV was observed in the right amygdala, a key emotional processing center.
Conversely, lower barostat urgency thresholds associated with increased GMV in the posterior insula — implicated in primary interoceptive visceral sensory processing — and in bilateral amygdala and right hippocampus, regions integral to emotion and memory processing. These distinct patterns suggest experimental urgency and real-life urgency map onto separate but overlapping neural circuits.
Clinical Correlations:
The specific linkage of barostat urgency to gastrointestinal-specific anxiety underscores the emotional sensitization in sensory processing, while symptom-based urgency’s association with broader abdominal symptoms highlights its embedding in clinical manifestation.
Expert Commentary
This pioneering study elucidates the complex neurobiological underpinnings of defecation urgency in IBS, distinguishing sensory versus emotional components and their distinct neural correlates.
The finding that symptom diaries and questionnaires correlate while experimental thresholds diverge emphasizes the need for multidimensional assessment in clinical practice. Sensory testing may capture mechanistic sensitivity, but patients’ lived experience reflects emotional modulation and cognitive appraisal.
The involvement of the anterior cingulate cortex and amygdala aligns with existing literature demonstrating their role in pain modulation and emotional integration in IBS. Increased amygdala volume may reflect neuroplastic changes linked to chronic visceral distress and anxiety.
Limitations include the cross-sectional design precluding causal inference and potential variability in barostat testing protocols. Future longitudinal studies should assess how brain morphology evolves with symptom trajectories and treatment.
Conclusion
Defecation urgency in IBS represents a multidimensional symptom complex involving distinct sensory and emotional neural substrates. Differentiating experimentally induced rectal sensation thresholds from real-life symptom reports reveals divergent brain structural correlates, highlighting the importance of integrating both dimensions for comprehensive patient assessment.
This work advances mechanistic understanding and informs future interventions targeting both visceral sensory processing and emotional factors to improve management of urgency and overall IBS burden.
Funding and ClinicalTrials.gov
The study was conducted at a specialized gastroenterology clinic and funded by institutional grants. No specific clinical trial registration is reported.
References
1. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150(6):1393-1407.e5.
2. Labus JS, Mayer EA. Functional GI disorders: Bridging the brain-gut divide. Adv Exp Med Biol. 2016;91-105.
3. Tillisch K, Mayer EA, Labus JS. Imaging brain function in IBS: a neuroimaging review. Gastroenterology. 2011;140(2):71-89.
4. Balaban CD, Jacob RG. Brain structures and pathways involved in vestibular-autonomic control. Front Neurol. 2016;7:23.
5. Mayer EA, Tillisch K, Bradesi S. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther. 2006;24(6):919-933.
